Tweenvest Stocks

Qlucore AB (publ) (OM: QCORE)

Health Care · Health Care Technology · SE

Skr0.38

-5.71% today · -57.3% 1Y

Qlucore AB (publ) (OM: QCORE) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $1.72M and employs 15 people.

Over the last twelve months the share price has lost 57.3%, trading between 0.21 and 1.10.

Tweenvest scores Qlucore AB (publ) across four factors: quality 36/100, value 50/100, growth 0/100. Its strongest factor is value.

QCORE price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$1.72M
Revenue (TTM)
$1.12M
P/E
EPS
-1.22
Dividend yield
Beta (5Y)
0.37
52-week high
Skr1.10
52-week low
Skr0.21
Avg volume (3M)
Shares outstanding
42.90M
Employees
15
Next earnings

About Qlucore AB (publ)

Based in Lund, Sweden, Qlucore AB (publ) delivers advanced bioinformatics data analysis tools for global application in both scientific research and accurate medical diagnostics. Its product suite includes Qlucore Omics Explorer, an AI-powered bioinformatics software designed for research across various sectors such as life science, biotechnology, food, plant industries, and academia. Additionally, the company offers Qlucore Diagnostics, a specialized software platform for multi-omics companion and precision diagnostics, as well as Qlucore Insights, which facilitates the analysis of clinical data. Qlucore was established in 2007.

Founded
2007
Listed since
Nov 5, 2021
Exchange
OMX Nordic Exchange Stockholm
Currency
SEK
CompanyMarket capPriceDay
Veeva Systems Inc.NYSE: VEEV$40.27B$247.90-1.05%
Pro Medicus LimitedASX: PME$14.35BAU$191.60-6.99%
M3, Inc.TSE: 2413$7.17B¥1,708.00-2.43%
Sectra AB (publ)OM: SECT B$5.66BSkr278.00-1.35%
Waystar Holding Corp.NasdaqGS: WAY$4.80B$25.01+0.68%
Doximity, Inc.NYSE: DOCS$4.51B$25.33-2.35%
HeartFlow, Inc.NasdaqGS: HTFL$3.66B$49.66+18.01%
Inventurus Knowledge Solutions LimitedNSEI: IKS$3.30BRs1,840.00+6.43%

Browse every Health Care Technology company →

Figures last refreshed Aug 18, 2026.